These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias. Fitton A; Buckley MT Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581 [TBL] [Abstract][Full Text] [Related]
3. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias. Anderson JL Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254 [TBL] [Abstract][Full Text] [Related]
4. Moricizine: a new class I antiarrhythmic. Mann HJ Clin Pharm; 1990 Nov; 9(11):842-52. PubMed ID: 2272151 [TBL] [Abstract][Full Text] [Related]
5. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Cardiac Arrhythmia Pilot Study (CAPS) Investigators Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169 [TBL] [Abstract][Full Text] [Related]
6. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine. Snyder DW J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol. Pratt CM; Butman SM; Young JB; Knoll M; English LD Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586 [TBL] [Abstract][Full Text] [Related]
8. Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances. Pratt CM; Luck JC; Mann DE; Wyndham CR Cardiol Clin; 1984 Feb; 2(1):35-46. PubMed ID: 6443563 [TBL] [Abstract][Full Text] [Related]
9. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias. Hession MJ; Lampert S; Podrid PJ; Lown B Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587 [TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy. Salerno DM; Sharkey PJ; Granrud GA; Asinger RW; Hodges M Clin Pharmacol Ther; 1987 Aug; 42(2):201-9. PubMed ID: 3301153 [TBL] [Abstract][Full Text] [Related]
11. Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis. Pratt CM Am J Cardiol; 1990 Feb; 65(8):51D-55D; discussion 68D-71D. PubMed ID: 1689536 [TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine. Podrid PJ; Beau SL Am J Cardiol; 1990 Feb; 65(8):56D-64D; discussion 68D-71D. PubMed ID: 2407092 [TBL] [Abstract][Full Text] [Related]
13. Placement of moricizine in the selection of antiarrhythmic drug therapy. Morganroth J Am J Cardiol; 1990 Feb; 65(8):65D-67D; discussion 68D-71D. PubMed ID: 2407093 [TBL] [Abstract][Full Text] [Related]
14. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. Cardiac Arrhythmia Suppression Trial (CAST) Investigators N Engl J Med; 1989 Aug; 321(6):406-12. PubMed ID: 2473403 [TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic drug therapy of ventricular arrhythmias. Huang SK; Marcus FI Curr Probl Cardiol; 1986 Apr; 11(4):177-240. PubMed ID: 3086035 [No Abstract] [Full Text] [Related]
18. Clinical pharmacology of antiarrhythmic agents. Kelliher GJ; Kowey P; Engel T; Wetstein L Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883 [No Abstract] [Full Text] [Related]
19. New drugs in the management of ventricular arrhythmias. Sanna GP G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894 [TBL] [Abstract][Full Text] [Related]
20. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment. Bigger JT Am J Cardiol; 1990 Feb; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]